Lynx1 Capital Management LP Bionomics Limited Transaction History

Lynx1 Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.69 - $1.2 $413,774 - $719,607	599,673 New	599,673 $461,000
Q1 2024 May 15, 2024	SELL	$0.89 - $1.38 $8,755 - $13,576	-9,838 Reduced 1.19%	814,467 $838,000
Q4 2023 Feb 14, 2024	BUY	$1.13 - $4.46 $9,936 - $39,216	8,793 Added 1.08%	824,305 $1.22 Million
Q3 2023 Nov 14, 2023	BUY	$0.95 - $3.37 $774,736 - $2.75 Million	815,512 New	815,512 $2.2 Million

1.64M

Ticker BNOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,518,620
Market Cap $3.98M
Description
Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has ...

Get notified when there are updates to the investment portfolio of Lynx1 Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Lynx1 Capital Management LP with notifications on news.